Accessibility Menu
Biotage Ab (publ) logo

Biotage Ab (publ)(OTC) BITGF

This security has been delisted. This page is retained for historical reference.

Biotage Ab (publ) last closing stock price
MetricPriceDate
Last closeUSD 15.012025-07-10
Biotage Ab (publ) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 15.012025-07-02
1 month+0.97%USD 14.872025-05-23
3 month+74.62%USD 8.602025-04-07
Year to date+3.26%USD 14.542024-12-27
1 year-2.4%USD 15.382024-06-28
3 year-7.82%USD 16.292022-06-16
5 year+7.78%USD 13.932020-07-01
Since inception+1,205.61%USD 1.152005-10-06

BITGF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

BITGF Financials

Key Financial Metrics (TTM)

Gross Margin

62.69%

Operating Margin

18.63%

Net Income Margin

13.81%

Return on Equity

7.31%

Return on Capital

8.78%

Return on Assets

5.56%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

45.07%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

SEK 1.23B

Operating Income

SEK 224.00M

EBITDA

SEK 484.00M

Operating Cash Flow

SEK 1.66B

Capital Expenditure

-SEK 1.01B

Free Cash Flow

SEK 655.90M

Cash & ST Invst.

SEK 420.00M

Total Debt

SEK 238.00M

Biotage Ab (publ) Performance Analysis

Biotage Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31SEK 143,511,630N/A
20222022-12-31SEK 154,744,7137.8%
20232023-12-31SEK 175,396,55513.3%
20242024-12-31SEK 194,462,53010.9%
Biotage Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-305.0%
Q32024-09-30-2.8%
Q42024-12-3118.8%
Q12025-03-31-33.8%
Biotage Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31SEK 0.36N/A
20222022-12-31SEK 0.409.7%
20232023-12-31SEK 0.31-21.7%
20242024-12-31SEK 0.347.1%
Biotage Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3046.3%
Q32024-09-30-6.7%
Q42024-12-31253.6%
Q12025-03-31-97.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

SEK 385.00M

-19.8%

Gross Profit

SEK 242.00M

-20.1%

Gross Margin

62.86%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

622

N/A

Net Income

SEK 4.00M

-87.9%

EBITDA

SEK 28.00M

-75.0%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Total Cash

SEK 420.00M

-38.5%

Total Debt

SEK 238.00M

-40.5%

Accounts Receivable

SEK 309.00M

-15.1%

Inventory

SEK 439.00M

-0.9%

Long Term Debt

SEK 207.00M

-43.6%

Short Term Debt

SEK 31.00M

-6.1%

Return on Assets

5.56%

N/A

Return on Invested Capital

8.47%

N/A

Free Cash Flow

SEK 11.00M

-98.5%

Operating Cash Flow

SEK 43.00M

-96.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DGWPFDrägerwerk AG & Co. KGaA
$93.00+12.05%
MDRSFMedartis Holding AG
$115.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.